SHANNON RASMUSSEN: Open Payments
NPI 1134748080 · DOWNEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,638 in 68 payments from 13 companies in 2025. Trend: 2023 $371 · 2024 $538 · 2025 $1,638
Food & beverage: $1,638
| Company | Payments | Amount |
|---|---|---|
| Galderma Laboratories, L.P. | 20 | $531 |
| ABBVIE INC. | 15 | $281 |
| GENZYME CORPORATION | 5 | $196 |
| Amgen Inc. | 9 | $164 |
| Novartis Pharmaceuticals Corporation | 3 | $82 |
| LEO Pharma Inc. | 3 | $82 |
| Janssen Biotech, Inc. | 3 | $75 |
| Regeneron Healthcare Solutions, Inc. | 3 | $70 |
| Arcutis Biotherapeutics, Inc. | 3 | $68 |
| UCB, Inc. | 1 | $36 |
Products named: NEMLUVIO, DUPIXENT, RINVOQ, Otezla, SKYRIZI, ADBRY, TREMFYA, Zoryve.
Industry payments across CA — which companies pay providers there.
